1～4 item / All 4 items
What does the fusion of medical big data and AI (artificial intelligence) bring to the field of drug discovery? A detailed explanation of the current state and challenges of innovative drug discovery technologies!
Exploring the potential of AI drug discovery through the efforts of pharmaceutical companies, starting with large-scale projects!
Next-generation antibody and peptide aptamer drug discovery business!
Our company is engaged in drug discovery business for next-generation antibodies and peptide aptamers through in-house research, joint research, and alliances. Under the NEDO Research and Development Venture Support Program (STS) for the fiscal year 2017, we successfully automated the "genotype/phenotype molecular matching technology," one of the evolving molecular engineering technologies, enabling the automated preparation of a homogeneous cDNA display library with a diversity of 10^14 (hundreds of trillions). In addition to the naive VHH gene library through a technical partnership with RePHAGEN, we also possess a high-quality peptide gene library in-house. *For more details, please contact us.
![[Market Report] Global Computer-Aided Drug Discovery Market](https://image.mono.ipros.com/public/product/image/dc1/2000928396/IPROS95546462895383581063.jpeg?w=280&h=280)
Global Computer-Aided Drug Discovery Market: Driving Pharmaceutical Innovation through Cutting-Edge Technologies and Computational Methods
The global computer-aided drug discovery (CADD) market is innovating the pharmaceutical industry by harnessing the power of advanced technologies and computational methods. CADD accelerates drug discovery and development, enabling researchers to identify potential drug candidates, optimize molecular structures, and predict drug interactions more accurately and efficiently. According to the latest market research, the global CADD market was valued at $2.8 billion in 2021, and significant growth is expected during the forecast period from 2022 to 2030, with a compound annual growth rate (CAGR) of 12.5%. For application methods, please check the [PDF download] button or apply directly through the related links.
